Search for Clinical Trial Results
Diffuse Intrinsic Pontine Glioma - 27 Studies Found
Status | Study |
Completed |
Study Name: A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas Condition: Diffuse Intrinsic Pontine Glioma Date: 2002-05-10 Interventions:
|
Recruiting |
Study Name: Molecular Profiling for Individualized Treatment Plan for DIPG Condition: Diffuse Intrinsic Pontine Glioma (DIPG) Date: 2014-10-21 Interventions:
|
Completed |
Study Name: Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Condition: Recurrent Diffuse Pontine Gliomas Date: 2008-01-11 Interventions: Biological: nimotuzumab (anti EGFR humanized monoclonal antibody) 150 mg/m2 I.V. Induction phase: infusi |
Terminated |
Study Name: Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents Condition: Gliomas Date: 2012-01-11 Interventions:
|
Recruiting |
Study Name: Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma Condition:
Date: 2016-04-27 Interventions: Drug: Doxorubicin |
RECRUITING |
Study Name: FUS Etoposide for DMG - A Feasibility Study Condition: Diffuse Intrinsic Pontine Glioma Date: 2024-05-19 Interventions: Subjects will receive focused ultrasound sonication followed by once daily oral etoposide (50mg/m^2/dose).Oral etoposide will be taken |
RECRUITING |
Study Name: Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors Condition: Diffuse Intrinsic Pontine Glioma Date: 2024-05-19 Interventions: Courses of weekly intravenous SC-CAR4BRAIN infusions for 3 weeks, then 1 week off |